Chemotherapy | Treatments Promising Results: Pembrolizumab Enhances Mesothelioma Treatment ByHolly Zink December 7, 2023November 6, 2023 Pleural mesothelioma is a challenging cancer caused by asbestos exposure. It is often diagnosed in advanced stages with limited treatment…
Immune Systems | Immunotherapy New Hope for Treating Pleural Mesothelioma: Breakthrough Therapies on the Horizon ByHolly Zink December 5, 2023November 6, 2023 Pleural mesothelioma is a rare and tough cancer with a history of limited treatment options and a difficult prognosis. But…
Radiation Therapy | Treatments Expanding Treatment Horizons: CIRT’s Potential for Mesothelioma Patients ByHolly Zink December 2, 2023November 6, 2023 When it comes to treating early-stage cancer, surgery is often the recommended approach. But did you know that some patients…
New Studies | Research Unlocking Mesothelioma’s Secrets: Understanding the Tumor Microenvironment ByHolly Zink November 28, 2023November 15, 2023 Researchers are working hard to understand the area around mesothelioma tumors. This is known as the tumor microenvironment. The tumor…
Chemotherapy | Treatments Safety First: Managing Cisplatin Exposure After Mesothelioma Treatment ByHolly Zink November 27, 2023November 15, 2023 Mesothelioma is an aggressive type of cancer that affects the lining of the lungs, abdomen, or heart. It is caused…
Diagnosis Understanding Mesothelioma: The Impact of BAP1 and p16 in Accurate Diagnosis ByHolly Zink November 22, 2023November 15, 2023 Mesothelioma is a rare and serious type of cancer that affects the lining of organs like the lungs and abdomen.…
Multi-Modality Therapy | New Studies | Statistics Decoding Pleural Mesothelioma: Insights from a Ten-Year Study ByHolly Zink November 21, 2023November 3, 2023 Recently, a group of researchers studied 169 patients with pleural mesothelioma over ten years. They wanted to gain a deeper…
Diagnosis | New Techniques The Future of Mesothelioma Diagnosis: A Faster, More Affordable Solution ByHolly Zink November 19, 2023November 3, 2023 A new study’s groundbreaking findings show that using both MTAP and p16 IHC can be a powerful tool in diagnosing…
Biomarkers Paradigm Shift in Mesothelioma Treatment: Targeting PD-1 Biomarker for Improved Outcomes ByHolly Zink November 17, 2023November 3, 2023 A recent study in mesothelioma patients opens a new chapter in the fight against this challenging disease. It enhances our…
Prognosis | Treatments Meet FLT PET: A New Hope for Mesothelioma Patients ByHolly Zink November 15, 2023November 1, 2023 There’s a new tool called F18-Fluorothymidine (FLT) PET. It takes pictures inside the body and focuses on how the cancer…